Prognostic factors for brain metastases from non-small cell lung cancer with EGFR mutation: influence of stable extracranial disease and erlotinib therapy
Crossref DOI link: https://doi.org/10.1007/s12032-014-0228-9
Published Online: 2014-09-11
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sekine, Akimasa
Satoh, Hiroaki
Iwasawa, Tae
Tamura, Katsumi
Hayashihara, Kenji
Saito, Takefumi
Kato, Terufumi
Arai, Mito
Okudela, Koji
Ohashi, Kenichi
Ogura, Takashi
Text and Data Mining valid from 2014-09-11